Based in Atlanta, BP Genomics has launched a molecular test that detects only the 2019 strain of the coronavirus. They have collaborated with a number of partners to develop a kit that extracts the RNA from a swab or saliva collection device, purifies the sample and runs a molecular test known as qPCR to detect the 2019_nCoV strain of the virus.